A recombinant partial protein sequence (within amino acids 50-150) from the human protein was used as the immunogen for the recombinant NAPSA antibody antibody.
Optimal dilution of the recombinant NAPSA antibody antibody should be determined by the researcher.
Restrictions
For Research Use only
Format
Liquid
Concentration
0.2 mg/mL
Buffer
0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
Aliquot the recombinant NAPSA antibody antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Target
NAPSA
(Napsin A Aspartic Peptidase (NAPSA))
Alternative Name
NAPSA
Background
Napsin is a pepsin-like aspartic proteinase connected with maturation of surfactant protein B.There are two closely related napsins, napsin A and napsin B. Napsin A is expressed as a single chain protein. Immunohistochemical studies revealed high expression levels of napsin A in human lung and kidney but low expression in spleen. Napsin A is expressed in type II pneumocytes and in adenocarcinomas of lung. The high specificity expression of napsin A in adenocarcinomas of lung is useful to distinguish primary lung adenocarcinomas from adenocarcinomas of other organs.